RGFP966 inhibits activation of AIM2 inflammasomes to promote mitophagy to relieve acute gouty arthritis
Zewei Wang, Chunyang Liu, Feng Cheng, Xiuyun Shi, Jing Dai, Jing Tian, Hongxu Jin, Ying Liu · 2026
Read RGFP966 inhibits activation of AIM2 inflammasomes to promote mitophagy to relieve acute gouty arthritis by Zewei Wang, Chunyang Liu, Feng Cheng, Xiuyun Shi, Jing Dai, Jing Tian, Hongxu Jin, Ying Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0348274.txt.
Description
Zewei Wang and colleagues tested a drug already known to cancer researchers as a reliever of acute gout in rats. Gout flares when urate crystals ignite an immune alarm complex inside joints. The drug blocks a gene-silencing enzyme and, through that, the alarm. Rats with crystal-injected joints received the drug or the standard gout medicine colchicine, and their joints, blood, and tissues were examined closely.
Treated rats walked better, with less swelling and milder joint inflammation, and their blood carried far less of the inflammatory messengers gout releases. The joint alarm complex quieted, while the cells' internal recycling and energy recovered, shown by restored power levels and revived cleanup proteins. Kidney damage eased too. The authors trace the benefit to calming the alarm while boosting cellular cleanup, and propose the drug as a gout candidate.
Catalog record
| CREATOR | Zewei Wang, Chunyang Liu, Feng Cheng, Xiuyun Shi, Jing Dai, Jing Tian, Hongxu Jin, Ying Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35390 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |